Flexion Therapeutics Just Hit A Major Milestone By: Benzinga via Benzinga October 09, 2017 at 11:53 AM EDT Flexion Therapeutics Inc (NASDAQ: FLXN) announced last week it has received regulatory approval for its Zilretta therapy represents a ... Read More >> Related Stocks: Flexion Therapeutics